Mycotic aneurysms of the common femoral artery are rare and usually occur in intravenous drug abusers who use the femoral vessels for injection. We herein describe a case of mycotic aneurysm of the common femoral artery caused by methicillin-sensitive Staphylococcus aureus seeding of an atherosclerotic plaque in which the bacteria possibly originated from psoriatic skin lesions. A 67-year-old Caucasian man was admitted to the hospital after experiencing chest pain for two days. He was known to have psoriasis and coronary artery disease with a history of coronary artery bypass grafting surgery three years earlier. He was found to have methicillin-sensitive Staphylococcus aureus bacteremia and later developed a mycotic aneurysm of the femoral artery opposite to the site of catheterization access. Mycotic aneurysms are rare clinical conditions associated with significant morbidity and mortality. In patients with psoriasis, a high prevalence of Staphylococcus aureus colonization of the skin makes possible bacterial seeding of existing atherosclerotic plaques. Therefore, the risk of mycotic pseudoaneurysm formation in these patients should be considered.
Introduction
The term mycotic pseudoaneurysm refers to an arterial wall injury leading to an abnormal aneurysmal dilatation that is usually associated with local or systemic infection or direct damage of a vessel wall after an interventional procedure. The incidence of mycotic pseudoaneurysms is low and diagnosis is challenging, as patients with mycotic pseudoaneurysms may present with non-specific symptoms. Mortality is high if diagnosis and treatment are delayed (1) .
Mycotic pseudoaneurysms of the common femoral artery are rare and usually occur in intravenous drug abusers who use the femoral vessels for injection. In these patients, the development of mycotic pseudoaneurysms is most likely due to direct damage of the arterial wall and/or an increased incidence of inoculation with microorganisms, especially Staphylococcus aureus (S. aureus) (2) .
Patients with psoriasis are known to have aberrant immune responses and thus a higher incidence of various infections, many of which are caused by Streptococcus or S. aureus (3) . We herein present the case of a patient with psoriasis who developed a mycotic pseudoaneurysm of the common femoral artery due to methicillin-sensitive Staphylococcus aureus (MSSA) seeding of an atherosclerotic plaque. The source of the bacteremia was presumed to be colonization of the psoriatic skin lesions. To the best of our knowledge, this is the first case report in the literature to describe an association between a mycotic pseudoaneurysm and MSSA bacteremia in a patient with psoriasis. been an ex-smoker for more than 10 years with no history of intravenous drug use. His current medications included aspirin, clopidogrel, carvedilol, amlodipine, olmesartan, atorvastatin, metformin and allopurinol. His pain was moderate, intermittent and pressure-like with a gradual onset accompanied by one episode of fever (102°F) and chills the day prior to the admission.
The patient was sent to the emergency department. A physical examination revealed an irregular heart rhythm (94-110 bpm), a respiratory rate of 21 and a blood pressure of 99/60 mmHg. A pansystolic murmur with maximum intensity over the aortic area was noted. Additionally, the patient had plaque-type psoriasis with lesions over the extensor surface of both forearms and scalp. The lesions were raised and covered with silvery-white scales with minimal scratch marks; however, no signs of active inflammation were observed.
The laboratory findings revealed a positive result for troponin I (1.03 ng/mL), an increased level of brain natriuretic peptide (5,380 pg/mL), a white blood cell count of 6,900 mm 3 (differential: neutrophils 86%, bands 1%, lymphocytes 6%, monocytes 1%), a hemoglobin level of 12.5 g/dL, a hematocrit of 36.6%, a platelet count of 197,000 mm 3 , a glucose level of 352 mg/dL, a blood urea nitrogen level of 22 mg/dL, a creatinine level of 1.2 mg/dL, a sodium level of 131 meql/L, a potassium level of 4 meq/L, a chloride level of 94 meq/L, a bicarbonate level of 25 meq/L, a glomerular filtration rate of 64 mL/min, an aminotransferase aspartate level of 31 U/L, an aminotransferase alanine level of 22 U/ L, a total protein level of 6 mg/dL, an albumin level of 3.5 mg/dL and an alkaline phosphatase level of 4 U/L.
Electrocardiography showed atrial flutter with a rapid ventricular rate of 110 bpm and no ST-T wave changes. The patient was admitted to the Cardiac Care Unit and administered treatment with diltiazem, carvedilol, clopidogrel, aspirin, therapeutic enoxaparin, a statin, cefepime and vancomycin. Transesophageal echocardiogram (TEE) showed severe aortic stenosis without vegetation and coronary angiography demonstrated the presence of patent grafts with no new lesions and an ejection fraction of 60% (coronary catheterization was performed with access through the right groin).
Blood cultures drawn on admission grew MSSA in two different sets, and the patient began treatment with nafcillin. No foci of infection were identified; the only possible source of infection was the psoriatic skin lesions. On the fourth day of hospitalization, the patient suddenly experienced severe tearing pain and noticed a palpable, erythematous mass in the left groin. Doppler ultrasound showed a 2.5 cm outpouching from the left common femoral artery and CT-angiogram of the aorta, pelvis and both lower extremities showed the presence of two aneurysms, one each on the medial and lateral aspects of the left common femoral artery, with irregular morphologies suggestive of arterial wall destruction (Fig. 1) .
The findings noted on CT-angiogram along with persistent MSSA bacteremia detected in repeated blood cultures suggested a diagnosis of mycotic aneurysm of the common femoral artery. The patient underwent immediate vascular surgical intervention with aneurysmal resection, debridement of the periarterial necrotic tissue and placement of a great saphenous vein interposition graft (Fig. 2) . The pathology reports confirmed the diagnosis of a common femoral artery pseudoaneurysm and moderate atherosclerosis at the site. Fluid collected intraoperatively from the tissue surrounding the aneurysm also grew MSSA. The clinical course of the patient was favorable.
Discussion
Clinical suspicion in the diagnosis of mycotic aneurysms is fundamental, as it allows for early diagnosis and treat-ment, which improves the likelihood of favorable outcomes. The possibility of aneurysmal rupture and death is high if treatment is delayed (4) .
Before the introduction of antibiotics, syphilis, tuberculosis and untreated endocarditis were among the most common causes of mycotic aneurysms (5, 6) . Today, intravenous drug abuse, dental extraction and angiographic procedures are the most common predisposing conditions (2, 7-9). Mycotic aneurysms have also been reported in patients with immunodeficiency (10) .
The most common bacteria associated with mycotic aneurysms is S. aureus; however, the involvement of other organisms such as Candida albicans, Salmonella, Escherichia coli and Streptococcus pneumoniae have been reported (10-13). There are also reports of mycotic pseudoaneurysms associated with heart transplantation (14), alcoholic cirrhosis (15) , Down syndrome (16) and Cushing's disease (17) ; however, an association between mycotic aneurysms and psoriasis has not been previously described in the literature.
In this case, the pathological process most likely responsible for the observed pseudoaneurysm formation was transient bacteremia originating from psoriatic lesions. As there was no evidence of infective endocarditis on TEE, no history of intravenous drug use and coronary catheterization was performed with access through the opposite groin, all other possible sources of infection could thus be ruled out.
It has been well established that patients with psoriasis have a high prevalence of skin colonization with different microorganisms, especially Staphylococcus aureus (18) . Balci and coworkers studied the prevalence of S. aureus and Staphylococcal enterotoxins in 50 patients with psoriasis. They found a high prevalence of colonization by S. aureus in this group of patients and reported that 96.8% of the strains isolated from lesional and non-lesional skin were toxigenic (p=0.01) (19) .
Even though the patient's psoriatic lesions were not inflamed, there was evidence of a disruption of the integrity of the skin over the psoriatic lesions characterized by the presence of scratch marks. Additionally, the absence of signs of active inflammation does not rule out the skin as the source of the bacteremia. Patients with psoriasis have an impaired immune response to pathogens that can lead to an increased risk of infection (20) . It has been reported that patients with psoriasis have an increased risk of persistent bacteremia caused by S. aureus despite an absence of actively inflamed skin lesions (21, 22) .
High rates of cutaneous colonization by S. aureus and subsequent S. aureus bacteremia have been reported to occur in several dermatological diseases. Published case reports have described atopic dermatitis lesions as important sources of bacteremia and have discussed the possibility of progression to serious complications, such as endocarditis due to invasive bacterial infection (23) .
Chronic inflammatory skin diseases, such as atopic dermatitis, psoriasis and rosacea are characterized by the dysregulation of cutaneous innate immunity and an increased incidence of bacteremia (24) . Dysfunction of cathelicidin LL-37, a molecule proven to play a central role in innate cutaneous immunity, is expressed in all three of these diseases (25) .
This patient had type 2 diabetes mellitus. It is well known that many specific infections, including soft tissue infections, bacteremia and sepsis, tend to more commonly occur in diabetic patients. These infections occur with increased severity and are associated with a greater risk of complications in patients with diabetes (26) . Several aspects of immunity are altered in patients with diabetes. For example, polymorphonuclear leukocyte function is depressed, particularly when acidosis is present. Leukocyte adherence, chemotaxis and phagocytosis may also be affected (27) .
Our patient presented to the hospital complaining of chest pain and was found to have elevated levels of the cardiac biomarkers cardiac muscle troponin I (cTnI) and brain natriuretic peptide (BNP). A non-ST elevation myocardial infarction (NSTEMI) was diagnosed; however, coronary angiography failed to demonstrate any significant stenosis of the coronary arteries or grafts. These findings can be attributed to sepsis induced myocardial injury, as there is a high prevalence of elevated serum levels of cTn and other cardiac biomarkers in septic patients (28) . Approximately 50% of all patients presenting with severe sepsis and septic shock develop impairment of ventricular performance. Elevations in the cTn level correlate with the presence of left ventricular systolic dysfunction (29, 30) .
Elevated levels of cTn have been detected in 12-85% (median frequency: 43%) of patients treated in intensive care units for sepsis or systemic inflammatory response syndrome, according to a recent meta-analysis of 3,278 patients evaluated in 20 studies (31) .
Finally, to the best of our knowledge, this is the first case in which the formation of a mycotic pseudoaneurysm has been related to the presence of psoriasis as a risk factor. One report published by Gálvez et al. described five patients with mycotic pseudoaneurysms, one of whom had psoriatric arthritis. However, the formation of the pseudoaneurysm in that case was a direct complication of arteriography of the lower limbs, as the pseudoaneurysm developed 15 days after the procedure at the same site to establish arterial access (32) .
The clinical presentation in this case was not related to any interventional procedures, as the patient first presented with fever, thus suggesting that the bacteremia was present prior to angiography. Additionally, the aneurysm developed at the site opposite to the arterial access, suggesting no relationship with coronary catheterization as the cause of disruption of the arterial wall or inoculation with S. aureus.
In conclusion, this case highlights various points that should be taken into account in patients with psoriasis, such as the high incidence of skin colonization with different bacteria, particularly S. aureus, and the possibility of bacteremia. Skin colonization may therefore represent a pathologi-cal mechanism that increases the risk of many infectious complications, including the formation of mycotic pseudoaneurysms, in arteries with atherosclerotic lesions.
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